Brief: Aequus Prepares For Health Canada Regulatory Filing As Partner Receives Mdsap Certificate For Dry Eye Products
31/08/2020 13:37
Aug 31 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS PREPARES FOR HEALTH CANADA REGULATORY FILING AS
PARTNER
RECEIVES MDSAP CERTIFICATE FOR DRY EYE PRODUCTS
Source text for Eikon: ID:nGNX424QFQ
Further company coverage: AQS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange